Literature DB >> 28436946

Essential role for Bim in mediating the apoptotic and antitumor activities of immunotoxins.

A Antignani1, D Segal2,3, N Simon1, R J Kreitman1, D Huang2, D J FitzGerald1.   

Abstract

Protein synthesis is crucial for regulating cell homeostasis and, when unrestricted, it can lead to tumorigenesis. Immunotoxins derived from Pseudomonas exotoxin are antibody-toxin fusion proteins that inhibit protein synthesis of mammalian cells via ADP-ribosylation of the eukaryotic elongation factor-2. Here we investigate the role of the Bcl-2 family proteins in the response of cancer cells to immunotoxin challenge. Besides the well-known reduction of the prosurvival Bcl-2 family member, Mcl-1, following inhibition of protein synthesis, we show for the first time that immunotoxins also reduce the levels of selected proapoptotic BH-3-only proteins. Among these, only Bim protein levels correlated with the ability of immunotoxins to induce an apoptotic response. To support our findings, we verified that a Bim knockout completely abolished immunotoxin-mediated apoptosis. Further, mice bearing either wild-type or Bid knockout tumors responded to immunotoxin treatment with a decrease in growth kinetics, whereas mice engrafted with Bim knockout tumors showed no reduction in tumor size or prolongation of survival following immunotoxin treatment. From these results, we conclude that Bim expression is a major susceptibility factor for tumor cell death and, as such, constitutes a potential biomarker that could be evaluated before immunotoxin treatment. In support of this hypothesis, clinically, we analyzed patient cells before immunotoxin treatment and report that samples of hairy cell leukemia with high levels of Bim protein responded with a greater decrease in leukemic cell count compared with those samples expressing a low level of Bim.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28436946     DOI: 10.1038/onc.2017.111

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  24 in total

1.  Generation and characterization of novel monoclonal antibodies to the Ret receptor tyrosine kinase.

Authors:  Giuliana Salvatore; Satoshi Nagata; Marc Billaud; Massimo Santoro; Giancarlo Vecchio; Ira Pastan
Journal:  Biochem Biophys Res Commun       Date:  2002-06-21       Impact factor: 3.575

2.  Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function.

Authors:  Lin Chen; Simon N Willis; Andrew Wei; Brian J Smith; Jamie I Fletcher; Mark G Hinds; Peter M Colman; Catherine L Day; Jerry M Adams; David C S Huang
Journal:  Mol Cell       Date:  2005-02-04       Impact factor: 17.970

3.  ABT-737 overcomes resistance to immunotoxin-mediated apoptosis and enhances the delivery of pseudomonas exotoxin-based proteins to the cell cytosol.

Authors:  Roberta Traini; Gal Ben-Josef; Diana V Pastrana; Elizabeth Moskatel; Ashima K Sharma; Antonella Antignani; David J Fitzgerald
Journal:  Mol Cancer Ther       Date:  2010-06-29       Impact factor: 6.261

4.  Combining the antimesothelin immunotoxin SS1P with the BH3-mimetic ABT-737 induces cell death in SS1P-resistant pancreatic cancer cells.

Authors:  Kevin Hollevoet; Antonella Antignani; David J Fitzgerald; Ira Pastan
Journal:  J Immunother       Date:  2014-01       Impact factor: 4.456

5.  Phase I trial of anti-CD22 recombinant immunotoxin moxetumomab pasudotox (CAT-8015 or HA22) in patients with hairy cell leukemia.

Authors:  Robert J Kreitman; Martin S Tallman; Tadeusz Robak; Steven Coutre; Wyndham H Wilson; Maryalice Stetler-Stevenson; David J Fitzgerald; Robert Lechleider; Ira Pastan
Journal:  J Clin Oncol       Date:  2012-02-21       Impact factor: 44.544

Review 6.  Immunotoxins for leukemia.

Authors:  Alan S Wayne; David J Fitzgerald; Robert J Kreitman; Ira Pastan
Journal:  Blood       Date:  2014-02-27       Impact factor: 22.113

Review 7.  Bcl-2-regulated apoptosis: mechanism and therapeutic potential.

Authors:  Jerry M Adams; Suzanne Cory
Journal:  Curr Opin Immunol       Date:  2007-07-12       Impact factor: 7.486

Review 8.  A guide to taming a toxin--recombinant immunotoxins constructed from Pseudomonas exotoxin A for the treatment of cancer.

Authors:  John E Weldon; Ira Pastan
Journal:  FEBS J       Date:  2011-06-02       Impact factor: 5.622

9.  Downregulation of the antiapoptotic MCL-1 protein and apoptosis in MA-11 breast cancer cells induced by an anti-epidermal growth factor receptor-Pseudomonas exotoxin a immunotoxin.

Authors:  Yvonne Andersson; Siri Juell; Øystein Fodstad
Journal:  Int J Cancer       Date:  2004-11-10       Impact factor: 7.316

10.  A method for increasing the yield of properly folded recombinant fusion proteins: single-chain immunotoxins from renaturation of bacterial inclusion bodies.

Authors:  J Buchner; I Pastan; U Brinkmann
Journal:  Anal Biochem       Date:  1992-09       Impact factor: 3.191

View more
  7 in total

1.  Potentiated anti-tumor effects of BETi by MEKi in anaplastic thyroid cancer.

Authors:  Xuguang Zhu; Sunmi Park; Woo Kyung Lee; Sheue-Yann Cheng
Journal:  Endocr Relat Cancer       Date:  2019-09       Impact factor: 5.678

2.  Mitogen-activated protein kinase inhibition-induced modulation of epidermal growth factor receptor signaling in human head and neck squamous cell carcinoma.

Authors:  Guiqin Xie; Ailin Zhu; Xinbin Gu
Journal:  Head Neck       Date:  2021-02-03       Impact factor: 3.821

Review 3.  Development of Recombinant Immunotoxins for Hairy Cell Leukemia.

Authors:  Robert J Kreitman; Ira Pastan
Journal:  Biomolecules       Date:  2020-08-03

4.  Converged DNA Damage Response Renders Human Hepatocellular Carcinoma Sensitive to CDK7 Inhibition.

Authors:  Guiqin Xie; Ailin Zhu; Xinbin Gu
Journal:  Cancers (Basel)       Date:  2022-03-28       Impact factor: 6.639

5.  Synergistic effects of BET and MEK inhibitors promote regression of anaplastic thyroid tumors.

Authors:  Xuguang Zhu; Erik Holmsen; Sunmi Park; Mark C Willingham; Jun Qi; Sheue-Yann Cheng
Journal:  Oncotarget       Date:  2018-10-23

Review 6.  Mechanisms of Resistance to Immunotoxins Containing Pseudomonas Exotoxin A in Cancer Therapy.

Authors:  Michael Dieffenbach; Ira Pastan
Journal:  Biomolecules       Date:  2020-06-30

Review 7.  Targeting Receptors on Cancer Cells with Protein Toxins.

Authors:  Antonella Antignani; Eric Chun Hei Ho; Maria Teresa Bilotta; Rong Qiu; Robert Sarnvosky; David J FitzGerald
Journal:  Biomolecules       Date:  2020-09-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.